Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Stemline Therapeutics, Inc.
OKLAHOMA CITY, OK--(Marketwired - Feb 7, 2017) - On February 3, 2017, a class action lawsuit was filed in the United States District Court for the Southern District of New York against Stemline Therapeutics, Inc. (NASDAQ: STML). The complaint alleges …